{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:21Z","timestamp":1707525141216},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,21]]},"DOI":"10.7759\/cureus.42274","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T21:27:58Z","timestamp":1689974878000},"source":"Crossref","is-referenced-by-count":0,"title":["Fever, Cognitive Decline, and Multifocal T2 Hyperintensities on Brain MRI: A Case Report of Cytokine Release Syndrome"],"prefix":"10.7759","author":[{"given":"Nina M","family":"D'Amiano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Primiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Yedavalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona N","family":"Bahouth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen A","year":"2018","unstructured":"Shimabukuro-Vornhagen A, G\u00f6del P, Subklewe M, et al.. Cytokine release syndrome. J Immunother Cancer. 2018, 6:56. 10.1186\/s40425-018-0343-9","journal-title":"J Immunother Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-793141","article-title":"Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy","volume":"130","author":"Hay KA","year":"2017","unstructured":"Hay KA, Hanafi LA, Li D, et al.. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. Blood. 2017, 130:2295-306. 10.1182\/blood-2017-06-793141","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-802413","article-title":"Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights","volume":"130","author":"Obstfeld AE","year":"2017","unstructured":"Obstfeld AE, Frey NV, Mansfield K, et al.. Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights. Blood. 2017, 130:2569-72. 10.1182\/blood-2017-08-802413","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac5415","article-title":"Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia","volume":"7","author":"Porter DL","year":"2015","unstructured":"Porter DL, Hwang WT, Frey NV, et al.. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci Transl Med. 2015, 7:303ra139. 10.1126\/scitranslmed.aac5415","journal-title":"Sci Transl Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199004000-00009","article-title":"In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids","volume":"49","author":"Chatenoud L","year":"1990","unstructured":"Chatenoud L, Ferran C, Legendre C, et al.. In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids. Transplantation. 1990, 49:697-702. 10.1097\/00007890-199004000-00009","journal-title":"Transplantation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"Astct consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee DW","year":"2019","unstructured":"Lee DW, Santomasso BD, Locke FL, et al.. Astct consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant. 2019, 25:625-38. 10.1016\/j.bbmt.2018.12.758","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee DW","year":"2014","unstructured":"Lee DW, Gardner R, Porter DL, et al.. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014, 124:188-95. 10.1182\/blood-2014-05-552729","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2012.00152","article-title":"Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness","volume":"32","author":"Hobson EV","year":"2012","unstructured":"Hobson EV, Craven I, Blank SC. Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness. Perit Dial Int. 2012, 32:590-4. 10.3747\/pdi.2012.00152","journal-title":"Perit Dial Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10947-2","article-title":"Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19","volume":"269","author":"Gelibter S","year":"2022","unstructured":"Gelibter S, Bellavia G, Arbasino C, et al.. Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19. J Neurol. 2022, 269:2293-300. 10.1007\/s00415-021-10947-2","journal-title":"J Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s004150200012","article-title":"Acute disseminated encephalomyelitis in adults: a reappraisal of clinical, CSF, EEG, and MRI findings","volume":"249","author":"H\u00f6llinger P","year":"2002","unstructured":"H\u00f6llinger P, Sturzenegger M, Mathis J, Schroth G, Hess CW. Acute disseminated encephalomyelitis in adults: a reappraisal of clinical, CSF, EEG, and MRI findings. J Neurol. 2002, 249:320-9. 10.1007\/s004150200012","journal-title":"J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-009222","article-title":"Extensive acute disseminated encephalomyelitis in a young girl responding to intravenous methylprednisolone","volume":"2013","author":"Verma R","year":"2013","unstructured":"Verma R, Patil TB, Lalla R, Kumar M. Extensive acute disseminated encephalomyelitis in a young girl responding to intravenous methylprednisolone. BMJ Case Rep. 2013, 2013:bcr2013009222. 10.1136\/bcr-2013-009222","journal-title":"BMJ Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum DC","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020, 383:2255-73. 10.1056\/NEJMra2026131","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/160595-fever-cognitive-decline-and-multifocal-t2-hyperintensities-on-brain-mri-a-case-report-of-cytokine-release-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:19Z","timestamp":1707508879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/160595-fever-cognitive-decline-and-multifocal-t2-hyperintensities-on-brain-mri-a-case-report-of-cytokine-release-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.42274","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,21]]}}}